A decade after blockbuster $49.9 billion merger, former leaders say Minnesota-run medtech maker facing innovation reckoning.

Nearly 60 of the state’s biggest companies showcased their latest innovations, historical artifacts or community impact ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their ...

RBC Capital raised the firm’s price target on Medtronic (MDT) to $111 from $103 and keeps an Outperform rating on the shares as part of a broader ...

Neuralink President DJ Seo says its robotic surgical arm is the company's key differentiator, and could bring its implant to ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

In February, the FDA approved Medtronic’s BrainSense adaptive deep brain stimulation, which regulates the triggering brain ...

Stifel raised the firm’s price target on Medtronic (MDT) to $105 from $90 and keeps a Hold rating on the shares. After hosting an investor group visit and tour of Medtronic’s Boston HUGO soft tissue ...

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...

Embrace Gynecology becomes the third IDE clinical study for Hugo RAS in the U.S., demonstrating Medtronic’s commitment to ...

Cyber Surgery recently announced it launched its Alaya surgical robotic assistant for spine procedures in Europe.